2026-01-27 - Analysis Report
**Company Overview**
Accenture is a multinational management consulting, technology services, and outsourcing company.

**1. Return Rate Comparison**

* Cumulative Return of Review Stock (ACN): 53.14%
* Cumulative Return of Comparison Stock (S&P 500, VOO): 127.58%
* Divergence: -73.10 (max: 85.40, min: -93.00, relative divergence: 11.20%)

The cumulative return of ACN is lower than the comparison stock. The current divergence is -73.10.

**2. Recent Stock Price Fluctuations**

* Close: $280.71
* 5-day SMA: $280.06
* 20-day SMA: $276.88
* 60-day SMA: $263.24

The stock price is currently below the 5-day and 20-day SMAs, indicating a short-term bearish trend. The 60-day SMA is the farthest below the current price.

**3. RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence**

* Market Risk Indicator (MRI): 0.70 (High investment recommended)
* RSI: 61.68 (neutral)
* PPO: -0.15 (neutral)
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: -1.50 (worsening)
* 7-day Rank change: 48 (+) (rank up)
* 7-day Dynamic Expected Return change: 225.70 (+) (improving)
* Expected Return (%): 58.20% (Expected excess return compared to S&P 500 if invested long-term)

The MRI indicates a medium-risk investment. The RSI and PPO indicators are neutral. The hybrid signal is a buy.

**4. Recent News & Significant Events**

* [2026-01-26] Accenture (NYSE:ACN) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says - MarketBeat
* [2026-01-21] Accenture (ACN) Stock Trades Up, Here Is Why - Yahoo Finance
* [2026-01-26] Why Accenture (ACN) is a Top Momentum Stock for the Long-Term - Nasdaq
* [2026-01-26] 2 Reasons to Like ACN and 1 to Stay Skeptical - TradingView
* [2026-01-26] Buyouts & Robust Liquidity Aid Accenture Amid Fierce Competition - The Globe and Mail
* [2026-01-22] Accenture: I'm Starting A Position (Technical Analysis) - Seeking Alpha

The recent news indicates positive sentiment towards the company.

**4-2. Analyst Opinions**

* Analyst Consensus:
	+ Key: Buy
	+ Mean (1=StrongBuy~5=Sell): 2.04 (~Buy)
	+ Opinions: 27
	+ Target Price (avg/high/low): 291.98 / 330.00 / 210.00

The analyst consensus is a buy with a target price of $291.98.

**5. Recent Earnings Analysis**

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-12-18 | 3.57 | $18.74B |
| 2025-10-10 | 2.27 | $17.60B |
| 2025-06-20 | 3.52 | $17.73B |
| 2025-04-10 | 3.52 | $17.73B |
| 2025-03-20 | 2.85 | $16.66B |

The earnings per share (EPS) and revenue have been fluctuating. The recent earnings report shows a significant increase in revenue.

**6. Financial Information**

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-11-30 | $18.74B | 33.07% |
| 2025-08-31 | $17.60B | 31.89% |
| 2025-05-31 | $17.73B | 32.87% |
| 2025-02-28 | $16.66B | 29.86% |
| 2024-11-30 | $17.69B | 32.92% |

### Capital and Profitability

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-11-30 | $30.87B | 7.16% |
| 2025-08-31 | $31.20B | 4.53% |
| 2025-05-31 | $30.55B | 7.19% |
| 2025-02-28 | $29.25B | 6.11% |
| 2024-11-30 | $29.19B | 7.81% |

The revenue and profit margin have been fluctuating. The equity and return on equity (ROE) have also been fluctuating.

**7. Comprehensive Analysis**

Accenture has a medium-risk investment profile, according to the MRI. The RSI and PPO indicators are neutral, and the hybrid signal is a buy. The recent news indicates positive sentiment towards the company. The analyst consensus is a buy with a target price of $291.98. The earnings per share and revenue have been fluctuating, and the equity and ROE have also been fluctuating.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.